Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BLACKROCK Municipal Income TRUST V.BFK.P


Primary Symbol: BFK

BlackRock Municipal Income Trust (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to provide current income exempt from federal income taxes. Under normal market conditions, the Fund invests at least 80% of its managed assets in investments the income from which is exempt from federal income tax (except that the interest may be subject to the alternative minimum tax). The Fund may invest directly in securities or synthetically through the use of derivatives. The Fund's investment policies provide that it invests at least 80% of its total assets in investment grade quality municipal obligations issued by or on behalf of states, territories and possessions of the United States and their political subdivisions, agencies or instrumentalities, each of which pays interest that, in the opinion of bond counsel to the issuer, is excludable from gross income for federal income tax purposes. Its investment adviser is BlackRock Advisors, LLC.


NYSE:BFK - Post by User

Post by PotLuck444on Nov 14, 2019 8:54am
38 Views
Post# 30349637

Aleafia to expand capacity, sell new products at Paris Read

Aleafia to expand capacity, sell new products at Paris Read

 

Aleafia to expand capacity, sell new products at Paris

 

2019-11-14 08:15 ET - News Release

 

Mr. Nicholas Bergamini reports

ALEAFIA HEALTH RECEIVES HEALTH CANADA APPROVAL TO EXPAND PROCESSING, SELL NEW PRODUCT FORMATS AT PARIS FACILITY

Aleafia Health Inc.'s wholly owned subsidiary, Emblem Cannabis Corp., has secured two Health Canada licence amendments that expand processing capacity, allowing for the sale of new product formats at its Paris processing facility. The amendments apply to the licensed and operational Paris location, which processes all of the Company's extraction, packaging and order fulfilment for Canadian and international sales.

Health Canada licence amendment doubles licensed processing area

Company can also now produce and sell edibles, topicals and extracts

Final site evidence package for Paris Phase II expansion has been submitted

As a result of the licence amendments, the Company is now authorized to produce and sell new product formats and has adequate, licensed production space to do so.

"These licence amendments are well timed, increasing the versatility of our Paris Facility, while ensuring we can move immediately to the production of new cannabis 2.0 formats," said Aleafia Health CEO Geoffrey Benic. "The additional processing capacity will also allow us to accelerate the production of oil-based products derived from our recent outdoor harvest."

The first Licence Amendment vastly increases the Company's ability to produce finished cannabis products by authorizing activities including extraction, packaging and labeling in four rooms that were previously only authorized for cannabis cultivation. The amendment doubles the Paris Facility's licensed processing space. The second Licence Amendment permits the Company to produce and sell edibles, topicals and extracts to the Canadian market.

PARIS FACILITY PHASE II EXPANSION

Following the issuance of the amended licence and closing of corresponding application, the Company submitted its final Site Evidence Package ("SEP") to Health Canada for the Phase II expansion of its Paris Processing facility. The final stage in the Company's licence amendment application for the proposed expansion, the SEP demonstrates that the facility is operational ready and meets all Health Canada requirements.

The Paris Phase II expansion, a 30,000 sq. ft. facility, is entirely dedicated to the extraction, production, packaging and distribution of high-margin, value-added cannabis health and wellness products. The expansion is purpose-built to meet European Union Good Manufacturing Practices ("EU-GMP") certification requirements. EU-GMP certified facilities demonstrate the highest level of pharmaceutical-grade quality, and securing the certification (along with applicable import and export permits) will allow Aleafia Health to begin exporting medical cannabis products to the European Union market.

About Aleafia Health:

Aleafia Health is a leading, vertically integrated cannabis health and wellness company with four primary business units: Cannabis Cultivation & Products, Health & Wellness Clinics, Cannabis Education, and Consumer Experience with ecommerce, retail distribution and provincial supply agreements.

We seek Safe Harbor.

© 2019 Canjex Publishing Ltd. All rights reserved.

Bullboard Posts